Skip to main content

Texas-Based Pharmaceutical Companies - Breakdown by City

[Monday, 18 March 2013: I just noticed that the directory I discuss in this post contains the following disclaimer: "The company listings in this directory are provided as a broad, representative sample of Texas companies in three major areas of the biotechnology industry. This directory is not a comprehensive source of all biotechnology or health-related companies in the state. Due to space limitations, the Office of the Governor Economic Development and Tourism division is unable to include all relevant firms in this document." Thus, whatever interpretations I make based on it should be considered a rough estimation at best.  -IH]

I've written a synopsis of the 2012 Texas Biotechnology Industry Report (see previous post), but I'm going to hold off on posting it here until it first comes out on the next issue of the Postdoc Informer, the UT Southwestern postdoctoral community's bimonthly newsletter. In the meantime, I decided to look a bit more closely at the directory of Texas-based pharmaceutical and medical device companies also mentioned in my previous post. It's great that such a directory exists, but I was really curious as to how these companies were distributed geographically. I decided to look at the pharmaceutical companies first. Eighty-eight companies are listed, and below is the breakdown of the list by city:



("Other" = Amarillo, Corpus Christi, Lubbock, Quitman, Texarkana, and Waco)

In a sense, the breakdown isn't surprising: the top four are the four largest metropolitan areas in Texas by population.

Next post:  the geographical breakdown of Texas-based medical device companies

(The list of companies in Excel format can be found here.)

Comments

Post a Comment

Popular posts from this blog

Comics About Patents (A Work In Progress)

Back in January and February of 2018, I spent some time creating two four-panel comics about the process of 1) obtaining patent protection, and 2) monetizing those patent rights by licensing them. I drew the comics to serve as an illustration of concepts that I often find myself explaining to others in the course of my work. I've already shared these comics through  Twitter  and  Facebook  (click on either of link to see more of the creative process!). However, I thought I'd share them with my blog's readership as well. Please enjoy! I'm really hoping to reignite this project at some point in the future and create more episodes. (Click on the images below to enlarge) Episode 1: Episode 2: - Isamu Hartman
Post a Comment
Read more

The Big Fish: Texas-Based Biomedical Companies listed on NYSE and NASDAQ

[Monday, 22 April 2013:  I added Hanger Inc. (HGR, NYSE), an Austin-based prosthetics and orthotics company I had originally missed, to the list] [Thursday, 02 May 2013:  fixed the location of Hanger Inc. (HGR, NYSE) - changed from Dallas to Austin] I have another few posts coming up on Texas-based awardees of the SBIR program. But first, a quick digression. +Levi Shapiro  asked me the following question during a phone conversation we had earlier today:  who are the "Big Players" in the Texas biomedical industry that are listed in the major stock exchanges? I knew about Luminex (LMNX, NASDAQ) off the top of my head. Other than that, though, I really had no idea. Following the advice of +Lauren Nise  , I used LexisNexis (courtesy of the UT Dallas Eugene McDermott Library ) to generate a list of publicly traded biomedical companies headquartered in Texas that are listed in either NYSE or NASDAQ. Here are the companies I found: (Open spreadsheet as a se...
Post a Comment
Read more

Developing Software: What Should Academic Researchers Keep in Mind? (Part 1)

Having never had any experience in software development when I entered the world of academic technology transfer back in 2013, I never expected to learn so much in the intervening years about software licensing and commercialization. It turns out that, even working in technology transfer at a medical institution, I encounter a surprising number of software-based technologies. Furthermore, with the recent rise in the use of AI/ML applications in biomedical research, the frequency at which I am presented with software in my work is only increasing.  Below is my first attempt at summarizing what I have learned thus far in managing software assets within an academic technology transfer setting. None of what I write here should be viewed as constituting legal advice. Furthermore, if you are an academic researcher, you should most definitely rely on the guidance you receive from your own institution’s own technology transfer office when navigating these waters! However, I’m sharing my ob...
Post a Comment
Read more